The choroid plexuses (CPs) play pivotal roles in the most basic aspects of neural function. Some of the roles of the CP include maintaining the extracellular milieu of the brain by actively modulating chemical exchange between the CSF and brain parenchyma, surveying the chemical and immunological status of the brain, detoxifying the brain, secreting a nutritive "cocktail" of polypeptides, and participating in repair processes following trauma. This diversity of functions suggests that even modest changes in the CP can have far reaching effects. Indeed, changes in the anatomy and physiology of the CP have been linked to several CNS diseases. It is also possible that replacing diseased CP or transplanting healthy CP might be useful for treating acute and chronic brain diseases. Here we describe the wide-ranging functions of the CP, alterations of these functions in aging and neurodegeneration, and recent demonstrations of the therapeutic potential of transplanted CP for neural trauma.
INTRODUCTION
There are numerous medical conditions with distinct choroidal pathology ranging from normal aging to Alzheimer's disease (AD) and stroke (16, 22, 59, 68) . Causal The choroid plexuses (CPs) lie within the brain ventricles where they produce the cerebrospinal fluid (CSF) relationships between choroidal changes and many medical conditions are poorly understood and some changes and form a unique interface between the peripheral blood and the CSF. The CPs were first identified in the in the CP are likely downstream sequelae from the primary clinical condition. But independent of whether the 3rd century BC, but their functions have gone largely unexplored. Although studies looking at the physiology pathology of the CP is directly or indirectly linked to a given disease, the brain is subjected to additional stress of the CP are in their infancy, it appears that the CP plays pivotal roles in an extraordinary range of pro-that over time may exacerbate the primary medical condition or lead to new ones. At the same time, the CP cesses that establish, survey, and maintain the biochemical and cellular status of the central nervous system (CNS) assists in recovery processes by secreting neuroprotective compounds (9, 15, 48) and acting as a site of neuro-under normal and pathological conditions.
As we learn more about the expansive participation genesis (3, 10, 18, 35, 40, 43, 46) suggesting both an ongoing and "as needed" role in cellular repair and replacement of the CP in brain function, it becomes apparent that this small, yet complex, organ is subject to subtle anatomical in the brain. Here we discuss the role of the CP in development, normal brain function(s), neuronal surveillance, and physiological changes with wide-ranging consequences. aging, and selected CNS disorders. We also present the THE CHOROID PLEXUS IS A FIRST LINE OF DEFENSE FOR THE BRAIN notion of transplanting CP cells to repair the damaged CNS.
The CP is in an ideal position to monitor the CSF BASIC STRUCTURE AND TRADITIONAL for noxious compounds or potentially damaging cellular ROLES OF THE CHOROID PLEXUS invasion. The CP protects the brain against acute neuro-The CP is located throughout the four ventricles of toxic insults by using a complex, multilayered detoxifithe brain. It is most extensive in the lateral ventricles cation system (25, 26) . The CP aids or impedes the overwhere it projects from the choroidal fissure and extends all biodistribution of drugs and toxic compounds by being from the interventricular foramen just prior to the tip of the source of a full compliment of metabolizing enthe temporal horn of the ventricle. It projects into the zymes including phase I-III enzymes for functionalizathird and fourth ventricles from the ventricular roof. tion, conjugation, and transport of drugs. CP contains (a) Grossly, the CP is lobulated with a single continuous high concentrations of glutathione, cysteine, and metallolayer of cells derived from the ependymal lining of the thioneins to sequester toxic agents circulating in the CSF, ventricles. Despite being derived from the ependymal (b) protective enzymes such as superoxide dismutase, glulining, these cells possess epithelial cell characteristics tathione-s-transferase, and glutathione peroxidase and reand are often referred to as choroidal epithelial cells.
ductase to protect against free radical oxidative stress, The choroidal epithelial cells rest on a basal lamina, and (c) organic ion transport systems and multidrug recontain a large central spherical nucleus with abundant sistance proteins for exporting noxious compounds from cytoplasm, and possess numerous villi on their luminal the CSF. surface (13) . Adjacent epithelial cells are connected by
The CP also monitors the CNS by actively participattight junctions to physically restrict the movement of ing in the neuroimmune system (i.e., immunosurveillance) substances to and from the CSF (i.e., the blood-CSF (17). The first indication that the CP mediated interacbarrier). Ultrastructurally, the epithelial cells of the CP tions and/or signaling between the peripheral immune contain numerous mitochondria needed to maintain their system and the brain came from demonstrations that the high respiratory metabolism and energy requirements CP contains inducible lymphoid cells. Following sys- (11) . Underlying the epithelial cells and basal lamina is temic administration of lipopolysaccharide or IL-6 there a dense vascular bed that provides a blood flow 4-7 is a rapid and transient induction of IL-1β and TNF-α. times greater than the rest of the brain (19) . The capillar-This activation initiates a process that spreads throughies are large with thin fenestrated endothelial walls and out the brain, suggesting that the CP relays information bridging diaphragms overlying the fenestrations. An exbetween the immune system and the brain through the tensive array of adrenergic, cholinergic, peptidergic, and coordinated local induction of proinflammatory cytoserotoninergic nerve fibers innervate the blood vessels kines (44) . Choroidal epithelial cells also constitutively and the epithelium (54). express MHC class I molecules and in some species The most recognized function of the CP is CSF prosuch as mice they also express MHC class II molecules duction (70). In humans, CSF volume is 80-150 ml and that are inducible with infectious agents such as rabies new CSF is formed at a rate of approximately 500 ml/ virus (36, 64) . In vitro, epithelial cells present foreign antiday. CSF is produced mainly by active secretion with gen and stimulate T-lymphocyte proliferation through a water entering the CSF from the blood along an osmotic MHC class II restricted mechanism (53) . Accessory molegradient or by specific water channels such as aquaporin cules important for leukocyte adhesion, such as L-selec- (55) . The epithelial cells replenish the CSF by moving tin, ICAM-1, and VCAM-1, are found at low levels on Na + , Cl − , and HCO 3 − from the blood to the ventricles to CP epithelial cells but can be upregulated during inflamcreate the osmotic gradient that drives the secretion of mation (74, 79) . The phagocytic Kolmer cells of the CP H 2 O. Within the CP, the barrier function is shifted from also display inducible MHC class I and II antigens and the vasculature to the epithelium where tight junctions proliferate when challenged with endotoxins (28) . This form between the epithelial cells to confer the permeantigen presentation capacity implies that the CP is part ability properties of the CP (77). On the external surface of an intrinsic surveillance system defending against of the brain the sheet of epithelial cells fold over onto blood-borne pathogens and CSF-localized antigens. themselves, forming a double-layered structure between THE CENTRAL SECRETORY ROLE OF THE the dura and pia known as the arachnoid membrane. As CHOROID PLEXUS IN BRAIN FUNCTIONING in the CP, the passage of substances from the blood across the arachnoid membrane is restricted by tight
The CP is in an excellent location for distributing molecules both locally and globally to the brain. The CP junctions between adjacent cells. The arachnoid membrane is generally (but not completely) impermeable to possesses numerous specific transport systems, contains a broad array of receptors, and also potentially serves as hydrophilic substances, and its role is forming the blood-CSF barrier is largely passive (28) . a major source of biologically active compounds (see Table 2 . Polypeptides in the Choroid Plexus Table 1 and Table 2 ). These capabilities allow the CP to monitor and respond to the biochemistry of the brain (32) demonstrated, in vitro, that a effects of these changes on brain functioning have not been directly tested, but it seems reasonable that such soluble factor related to Slit2 is secreted by the CP to aid in establishing a gradient of a repulsive cue guiding dramatic alterations would lead toward inadequate distribution of nutritive substances, additional cellular stress, cortical neurons away from the ventricular surface. Along these same lines, Yamamoto et al. showed that the CP and reduced clearance of toxic compounds, all of which could play a part in age-related cognitive and motor de-modulates neurite outgrowth in the developing cerebellum (80) . Using cocultures of explanted cerebellum and cline or the development of specific neurological disorders. CP from fetal and infant rats, it was confirmed that CP CHOROID PLEXUS secretes a soluble neurite growth factor that correlates AND NEURODEGENERATION: with the major milestones of cerebellar morphogenesis.
ALZHEIMER'S DISEASE The importance of the CSF distribution of soluble fac-AND ISCHEMIA AS EXAMPLES tors during development is also highlighted by the elo-Alzheimer's Disease quent work of Miyan and colleagues (50, 51, 56, 58) , who showed that hydrocephalus in rats significantly impairs
The age-related deficiencies of the CP are exacerbated in AD. Epithelial cell atrophy is greater, with cell cortical development, leading to the suggestion that the circulating CSF and its associated factors are vital for height decreasing up to 22% relative to age-matched controls (65) . Greater intracellular distribution of lipo-development along the entire length of the neural tube.
Most of our knowledge about the morphology and fuchsin vacuoles and Biondi ring tangles occurs (49, 78) . The epithelial basement membrane becomes very irregu-function of human CP during aging comes from control tissues in studies investigating changes in AD. In hu-lar and thickens an additional 28% beyond that seen in age-matched controls (65) . The stroma of the villi be-mans, the height of CP epithelial cells decreases by about 10-11% during life (65) . The aged epithelial cell comes fibrotic with extensive vascular thickening (37, 65) , and numerous hyaline bodies and calcifications occur cytoplasm becomes rich with Biondi Ring tangles and lipofuchsin deposits (78) and the nuclei appear irregular together with deposits of IgG, IgM, and C1q along the epithelial basement membrane. Further decreases in CSF and flattened as the basement membrane thickens (65) . The stroma also thickens and contains collagen fibers, secretion occur with turnover requiring up to 36 h in AD patients (68). hyaline bodies, calcifications, and psammoma bodies and the infiltrating arteries become thicker and fragmented
The further atrophy of the choroidal epithelial cells in AD is associated with decreased secretory activity and (68,69). These changes are not species specific as similar changes occur in the aged mouse and rat choroid transport functions. Levels of transthyretin (TTR), a CP synthesized molecule that associates with β-amyloid epithelial cells (66,73).
The functions of the CP are energy dependent, and peptide to form complexes, are >10% lower in AD (63) . Ascorbic acid and α-tocopherol levels, the two major the aging CP cannot maintain its normal energy output. The synthesis of lactate dehydrogenase and succinate-scavengers of free radicals of CSF, are decreased in AD, likely adding to oxidative stress (61,75). CSF folate and dehydrogenase, critical for anaerobic respiration and oxidative phosphorylation, declines in aging rats by 9% vitamin B 12 (important for methylation of numerous molecules) are lower (34, 62, 67) , while homocysteine, and 26%, respectively (23) . There are age-dependent increases in the number of cytochrome C oxidase-deficient which mediates lipid peroxidation and increases the production of toxic (E)-4-hydroxy-2-nonenal, is increased epithelial cells, altering the respiratory mitochondrial chain and decreasing cellular production of ATP (49) .
in AD CSF. The impaired ability of the CP to clear molecules from the CSF of AD patients has potentially pro-Reductions in Na + K + -ATPase and the Na + K + -2Cl − cotransporter also occur (12) . These anatomical and enzy-found implications (68). In rats, clearance of intraventricularly injected β-amyloid peptide decreases from matic deteriorations could underlie the diminution of CSF secretion that is decreased by up to 45% in animals 10.4 µl/min at 3 months of age to 0.71 µl/min at 30 months. Consequently, brain content of amyloid peptide (59) . Due to the decreased secretion and the simultaneously increased CSF volume caused by brain atrophy, increases from 7% at the end of CSF perfusion in young rats to 49% in old animals (59) . The increase of β1-40 CSF turnover is longer in elderly rats (7.9 h) than in young rats (2.2 h). In humans, CSF production dimin-and β1-42 amyloid peptide levels in elderly humans could be related to decreased clearance from the CNS. ishes from 0.41 ml/min at 28 years to 0.19 ml/min at 77 years. Coupled with age-related cerebral atrophy, the Decreased CSF production could also enhance protein glycation and the formation of β-amyloid oligomers turnover of CSF decreases to less than twice daily in elderly subjects versus three to four times daily in young (68). AD brain contains elevated levels of glycation products and deposits of amyloid peptide; senile plaques adults. Elevated CSF/plasma ratios have been reported for several proteins during aging (59) . The cumulative and fibrillary tangles contain advanced glycation prod-ucts (68). Glycation promotes protein aggregation, the that is temporally similar to the delayed neuronal death within the hippocampus (57); (b) enhanced growth hor-polymerization of tau microtubule-associated proteins, and protein β-amyloid peptide aggregation. The decrease mone immunoreactivity following ischemia in rats (60) in injured neurons, axons, glial cells proximal to the in-of CSF turnover, the increase of protein glycation, and the diminution of β-amyloid clearance could also induce farction, and on the CP epithelial cells; (c) increased expression of TGF-β (isoforms β1, β2, and β3) in CP oligomer formation and retention. As pointed out by Serot et al. (68) , these changes could lead to a greater following ischemia in rats (9,41,42). In each case, augmented synthesis of these choroidal molecules may play impoverishment of the brain, leading to methylation problems, increased oxidative stress and lipid peroxida-a role in neuronal survival and the recovery of function. Indeed, intraventicular administration of TGF-β1 and tion, decreased amyloid clearance, augmented tau protein polymerization, and amyloid peptide oligomers and growth hormone reduces the size of the infarct following ischemia (29, 30, 60) . These data also highlight the com-fibrillo formation.
As a cautionary note, causal relationships between plexity of the response of the CP to an ischemic event and imply that CP cell loss can adversely impact the choroidal changes, CSF production and/or turnover, and AD pathology are poorly understood. It is conceivable death of neighboring neurons while at the same time surviving CP cells may produce factors that can benefi-that some changes in CP function are actually downstream sequelae from the primary clinical condition. These rela-cially affect the outcome of neurons. tionships will undoubtedly become clearer with further HARNESSING THE CHOROID PLEXUS investigation.
FOR TRANSPLANTATION THERAPY Ischemia
The profound age-and disease-related changes in CP have clear implications for understanding disease pro-Numerous anatomical and secretory changes occur in the CP following cerebral ischemia (22) . Middle cere-cesses but also raise the unexplored possibility that replacing damaged CP or transplanting healthy CP into bral artery (MCA) occlusion in rats induces apoptotic cell death with nuclear DNA breaks occurring after 6 h local areas of cell degeneration can be therapeutic. The diminished function of the aged CP may be much like of ischemia (27) . The DNA fragmentation and cell death in the CP can affect neighboring neuronal systems. Fol-any number of diseases characterized by secretory cell dysfunction. In principle, transplanting or replacing a lowing ischemia, the CA1 pyramidal neurons in the hippocampus undergo delayed neuronal death evident around failing organ (such as CP) or specific cell type is a logical and direct means of restoring lost function. There is 48 h after the insult. It is unclear why this delayed cell death occurs, but an analysis of the time course of cell also the potential of harnessing the polypeptide synthesis of the CP through focused local delivery after transplan-loss in the CP versus the hippocampus supports the possibility that ischemia initiates a cycle of cell loss where tation into an ectopic brain region. The role of the CP in growth factor and nutrient production makes it a novel the death of CP cells at least precedes and perhaps adversely affects neighboring neurons (21) . DNA fragmen-potential source of stable, dose-controlled polypeptide delivery (15) . While the notion of using transplanting tation occurs in the CP 24 h after ischemia but diminishes by 48 h. In contrast, at 48 h DNA breaks are widespread CP cells to the damaged brain regions is a new idea, the studies conducted to date support the concept and war-in the medial CA1 region and at 72 h DNA fragmentation spreads laterally within the CA1 region (21) . Subse-rant further investigation. CP isolated and maintained in vitro exerts potent neu-quent studies extended these data, showing a dramatic increase in TUNEL-positive cells in the CP at 18-36 h roprotective effects (5,6). Conditioned media from alginate encapsulated and cultured CP protected embryonic postischemia, but not at 48 h. No TUNEL-positive cells were seen at 24 h in the CA1 hippocampal region, cortical neurons against serum deprivation-induced cell death. This effect was dose dependent and nearly com-clearly demonstrating that the cell death in the CP preceded cell death in the CA1 region.
plete when neurons were cultured with 10-30% conditioned media ( Fig. 1 and Fig. 2 ). Conditioned media from Whether CP cell death impacts distant neurons through disruption of the blood-CSF barrier or changes in the CP also enhanced neurite outgrowth and dopamine uptake on cultured neuroblastoma cells and on embryonic production of specific secreted factors remains unknown. The CP may produce or fail to produce factors capable mesencephalic tissue, respectively (Skinner et al., unpublished data). These data dovetail nicely with a study of minimizing neuronal damage. Indeed, there is evidence of time-dependent increased production of factors where mouse CP epithelial cells were cultured with dorsal root ganglion neurons (8). After 4-5 h of coculture, capable of mitigating neuronal loss. These changes include: (a) elevations in hippocampal cystatin C, a cysteine pro-the neurons developed elongated neuronal processes with elaborate branching patterns. Similar effects have tease inhibitor produced by the CP, following ischemia of neurite outgrowth. The ability of CP cells to provide a scaffold for the extension of neurites is consistent with h. Neurite length, the number of primary neurites, and the number of branches were all by coculture with cho-its known production of extracellular matrices including laminin and fibronectin (58, 81) . The trophic and tropic roid plexus. Interestingly, this effect appeared to be primarily due to contact with the choroidal epithelial cells, effects of CP establish potentially excellent circumstances for the protection and repair of damaged CNS as these tropic effects were notably lessened when only conditioned media were used. Because the neurons ex-architecture. Similar benefits of CP have been observed in vivo. tended long branched neurites even when the choroidal cells were killed by ethanol fixation, it was suggested Isolated CP obtained from rodents was tested for its neu- roprotective effects in a conventional rodent model of the CP transplanted rats were indistinguishable from normal animals on this task as they made greater than 9 stroke (5,6). Rats received a 1-h MCA occlusion immediately followed by transplantation of alginate-encapsu-out 10 correct responses (Table 4 ). Nissl-stained sections demonstrated that CP transplants significantly re-lated CP on the cortex overlying the striatal region that would be normally infarcted following MCA occlusion.
duced the volume of the striatal lesion produced by QA by approximately 80% (Table 5) . A significant protec-Behavioral testing on days 1-3 following surgery using the elevated body swing test and Bederson neurological tion of cholinergic but not diaphorase-positive neurons was also seen. Future studies should more carefully evalu-examination revealed profound motor and neurological impairments in control animals that were significantly ate the extent of anatomical protection produced by CP grafts. These data are the first to demonstrate that trans-improved in the study group that received alginate-encapsulated CP transplants (Table 3 ). Histological analysis planted CP cells can be used to protect striatal neurons from excitotoxic damage and that this strategy may ulti-revealed that the behavioral improvements were accompanied by a 35-40% decrease in the volume of striatal mately prove relevant for the treatment of HD. The delivery of neurotrophic factors via CP trans-infarction as assessed by 2,3,5-triphenyltetrazolium chloride staining (Table 3) .
plants to the site of injury also offers theoretical promise for treating spinal cord trauma. Recently, Ide and col-In a more recent study, neonatal porcine CP was encapsulated within alginate microcapsules and tested for leagues (33) grafted syngeneic fragments of CP into the dorsal funiculus (C2 level) of a damaged adult rat spinal its neuroprotective potential in a rat model of Huntington's disease (HD) (7). In these studies, the animals re-cord. At various times posttransplant, subsets of animals were evaluated histologically to confirm cell survival ceived stereotaxic transplants of either empty capsules or CP-loaded capsules directly into the striatum. Three and determine any regenerative effect on the damaged spinal cord. Electron microscopy and fluorescence histo-days later, the same animals received unilateral injections of the excitotoxin quinolinic acid (QA; 225 nmol) chemistry showed that epithelial cells of the grafted CP survived well and induced a robust regeneration of the into the ipsilateral striatum. After surgery, animals were behaviorally tested for function of their forepaws using damaged axons of the spinal cord. Injections of horseradish peroxidase into the sciatic nerve labeled regener-the placement test. As expected, the QA lesion produced a profile of anatomical and behavioral effects that re-ating fibers extending from the fasciculus gracilis into the graft within 7 days posttransplant. This effect was semble those seen in the clinical condition. Transplanted animals gained body weight postsurgery more rapidly than controls (Table 4 ) and also demonstrated significant evident for at least 10 months. Some axons elongated tionship has been established between a particular change in secreted products from CP and neuronal degeneration. rostrally into the dorsal funiculus and long-duration evoked potentials were recorded 5 mm rostral to the le-Finally, a greater understanding of the role of the CP in CNS diseases may continue to bolster the emerging con-sion 8-10 months after grafting. These findings indicate that CP epithelial cells have the ability to facilitate axo-cept of using transplantable CP cells for CNS diseases. The few transplant studies conducted to date have been nal growth, suggesting that they are capable of exerting both trophic and tropic effects in vivo.
generally encouraging but have not yet focused on determining the means by which transplanted CPs exert their CONCLUSION beneficial effects. Future efforts will need to systematically approach each potential clinical indication with There is a generally underappreciated, essential, and far-reaching role that the CP plays in enabling neural emphasis on optimizing the donor source and age of the transplanted cells; determining whether specific cell types function. The production and distribution of CSF by the CP provides mechanical protective buoyancy for the within the CP (i.e., purified epithelial cells) are most beneficial; identifying the optimal postinjury timing, trans-brain and spinal cord, serves as a nutritive milieu for neurons and glial cells by secreting numerous polypep-plant location, and dosage of cells to be grafted; whether CP functions within parenchymal tissue in the same tides and growth factors, and acts as a vehicle for removing waste products of cellular metabolism. The manner as within the CSF; the mechanism by which transplanted CP affords beneficial effects; and whether functions and potential of choroidal cells will likely become more apparent and appreciated over time for three these benefits are greater because of the native ability of CP to secrete a physiologically balanced and temporally interrelated reasons. First, several convergent data sets are documenting an increasingly detailed role of CP se-adjusted cocktail of bioactive compounds versus delivery of single agents. cretory products in normal brain development and functioning. Within the CNS, the CP is a robust producer of compounds that are potentially vital for growth and REFERENCES function. The role of the CP in maintaining extracellular
